|
|
|
|
| LEADER |
00000nab a2200000ua 4500 |
| 001 |
vtls010831123 |
| 003 |
SK-MaSNL |
| 005 |
20260303214227.0 |
| 008 |
230222s2012 xo |||||||||||||||||eng| |
| 035 |
|
|
|a (urnnbn)urn:nbn:sk:snk:ar-a06hyv
|
| 035 |
|
|
|a urn:nbn:sk:snk-ab5w30
|
| 035 |
|
|
|a (uuid)b0754934-4b2c-4026-b982-41e2c8920a5f
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a eng
|
| 044 |
|
|
|a xo
|c SK
|
| 100 |
1 |
|
|a Xie, J.
|4 aut
|9 1173345
|
| 245 |
1 |
0 |
|a Down-regulation of TCF21 is associated with poor survival in clear cell renal cell carcinoma
|c J. Xie, J. Zhao, L. Sun, Y. Wang, A. F. Tang, W. H. Li, X. X. Li, Y. H. Han, Y. T. Gui, Y. W. Ye, Y. С. Liu, Z. C. Guan, Z. M. Cai, Z. M. Jiang, Z. S. Li
|
| 700 |
1 |
|
|a Zhao, J.
|4 aut
|9 1207165
|
| 700 |
1 |
|
|a Sun, L.
|4 aut
|9 1167326
|
| 700 |
1 |
|
|a Wang, Y.
|4 aut
|9 794878
|
| 700 |
1 |
|
|a Tang, A. F.
|4 aut
|9 1249001
|
| 700 |
0 |
|
|a W. H. LI
|4 aut
|9 1249002
|
| 700 |
0 |
|
|a X. X. LI
|4 aut
|9 1249003
|
| 700 |
0 |
|
|a Y. H. HAN
|4 aut
|9 1249004
|
| 700 |
0 |
|
|a Y. T. GUI
|4 aut
|9 1249005
|
| 700 |
0 |
|
|a Y. W. YE
|4 aut
|9 1249006
|
| 700 |
0 |
|
|a Y. С. LIU
|4 aut
|9 1249007
|
| 700 |
0 |
|
|a Z. C. GUAN
|4 aut
|9 1249008
|
| 700 |
0 |
|
|a Z. M. CAI
|4 aut
|9 1249009
|
| 700 |
0 |
|
|a Z. M. JIANG
|4 aut
|9 1249010
|
| 700 |
0 |
|
|a Z. S. LI
|4 aut
|9 1249011
|
| 773 |
0 |
|
|t Neoplasma : journal of experimental and clinical oncology
|g Roč. 59, č. 6 (2012), s. 599-605
|
| 958 |
|
|
|a OND
|
| 958 |
|
|
|a EUIPO
|
| 958 |
|
|
|a article5
|
| 999 |
|
|
|c 2215949
|d 2217879
|